NCT03858166 2024-01-05
Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer
Shandong University
Phase 4 Terminated
Shandong University
University of Washington
Prolong Pharmaceuticals